Literature DB >> 6957239

Vindesine receptors in cells of a human leukaemia cell line.

K Totsuka, K Oshimi, H Mizoguchi.   

Abstract

To determine whether vindesine receptors are present in human leukaemic cells, K562 cells (established from chronic myelogenous leukaemia in blastic crisis) were incubated with 3H-vindesine. Binding of 3H-vindesine increased with incubation time and with increase in number of K562 cells. However, when excessive amounts of nonradioactive vindesine were added, the 3H-vindesine was displaced. Binding of 3H-vindesine was only inhibited by vinblastine, vincristine and vindesine. These results suggest that K562 cells have receptors for vindesine and that these receptors are common to vinca alkaloids. Scatchard analysis showed that the number of vindesine receptors differed according to the kind of cells tested. K562 and a T-cell leukaemia-derived cell line, MOLT-4, had more receptors than an acute promyelocytic leukaemia-derived cell line, HL-60, and normal blood lymphocytes. The degree of vindesine affinity to receptors did not differ markedly among the above-mentioned cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957239      PMCID: PMC2011119          DOI: 10.1038/bjc.1982.215

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Correlation of biologic data with physico-chemical properties among the vinca alkaloids and their congeners.

Authors:  R J Owellen; D W Donigian; C A Hartke; F O Hains
Journal:  Biochem Pharmacol       Date:  1977-07-01       Impact factor: 5.858

2.  Current status of estrogen receptors in human breast cancer.

Authors:  W L McGuire
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

3.  The binding of vinblastine to tubulin and to particulate fractions of mammalian brain.

Authors:  R J Owellen; D W Donigian; C A Hartke; R M Dickerson; M J Kuhar
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

4.  Interaction of drugs with microtubule proteins.

Authors:  L Wilson; J R Bamburg; S B Mizel; L M Grisham; K M Creswell
Journal:  Fed Proc       Date:  1974-02

5.  Studies on the binding of ( 3 H)vinblastine by rat blood platelets in vitro. Effects of colchicine and vincristine.

Authors:  C J Secret; J R Hadfield; C T Beer
Journal:  Biochem Pharmacol       Date:  1972-06-01       Impact factor: 5.858

6.  The binding of vincristine, vinblastine and colchicine to tubulin.

Authors:  R J Owellen; A H Owens; D W Donigian
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

7.  Vinblastine-induced precipitation of microtubule protein.

Authors:  R Marantz; M Ventilla; M Shelanski
Journal:  Science       Date:  1969-08-01       Impact factor: 47.728

8.  Definition of the cell cycle segment with special sensitivity to vinblastine.

Authors:  A M Chirife; G P Studzinski
Journal:  Proc Soc Exp Biol Med       Date:  1978-02

9.  Differences between vinblastine and vincristine in distribution in the blood of rats and binding by platelets and malignant cells.

Authors:  P W Gout; L L Wijcik; C T Beer
Journal:  Eur J Cancer       Date:  1978-11       Impact factor: 9.162

10.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

View more
  2 in total

1.  Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine: mechanism of inoculum effects.

Authors:  H Kobayashi; Y Takemura; T Ohnuma
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Effects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect).

Authors:  T Ohnuma; H Arkin; J F Holland
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.